Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Myeloid, Acute × tocilizumab × 90 days × Clear all

Sponsor

Conditions

Multiple Myeloma 9 Lymphoma, Non-Hodgkin 6 Melanoma 3 Carcinoma, Non-Small-Cell Lung 3 Breast Neoplasms 3 Urinary Bladder Neoplasms 2 Recurrence 2 Lymphoma 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Craniopharyngioma 2 Urethral Neoplasms 1 Ureteral Neoplasms 1 Stomach Neoplasms 1 Solid Tumors 1 Sarcoma 1 Pancreatic Neoplasms 1 Osteosarcoma 1 Nasopharyngeal Neoplasms 1 Mesothelioma 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lung Neoplasms 1 Liver Neoplasms 1 Kidney Neoplasms 1 Immune-related Adverse Events 1 Hematologic Neoplasms 1 Esophageal Neoplasms 1 Cytokine Release Syndrome 1 Carcinoma, Transitional Cell 1 Carcinoma, Merkel Cell 1

Interventions

venetoclax 87 Azacitidine 69 Cytarabine 52 fludarabine 43 Specimen Handling 36 Biopsy 26 Daunorubicin 25 Cyclophosphamide 25 Decitabine 24 fludarabine phosphate 22 Injections 19 Granulocyte Colony-Stimulating Factor 18 Busulfan 17 Whole-Body Irradiation 16 Stem Cell Transplantation 15 Idarubicin 15 Mycophenolic Acid 14 Melphalan 14 Tacrolimus 13 CPX-351 13 gilteritinib 11 decitabine and cedazuridine drug combination 11 Filgrastim 11 enasidenib 9 ivosidenib 8 Mitoxantrone 8 Methotrexate 8 Magnetic Resonance Spectroscopy 8 Gemtuzumab 8 Cladribine 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡